Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| M2 macrophages promote PKM2 production in fibroblasts to alleviate UVB-induced photoaging. | Cell Cycle | 2025 | 40474370 | PubTator, text mining | PubMed |
| Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy. | Immunity | 2025 | 40460833 | PubTator, text mining | PubMed |
| Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies. | J Virol | 2025 | 40377318 | PubTator, text mining | PubMed |
| Expansion of multiple CD4+ T-cell lineages in lymphocytic variant hypereosinophilic syndrome. | J Allergy Clin Immunol | 2025 | 40350095 | PubTator, text mining | PubMed |
| TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function. | Oncoimmunology | 2025 | 40293187 | PubTator, text mining | PubMed |
| Exploring predictive biomarkers of efficacy and survival with nivolumab treatment for unresectable/recurrent esophageal squamous cell carcinoma. | Esophagus | 2025 | 40274705 | PubTator, text mining | PubMed |
| CCR8+ decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy. | Sci Immunol | 2025 | 40249828 | PubTator, text mining | PubMed |
| CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype. | J Exp Clin Cancer Res | 2025 | 40186298 | PubTator, text mining | PubMed |
| A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. | Cell | 2025 | 40147443 | PubTator, text mining | PubMed |
| Macrophage-derived CCL1 targets CCR8 receptor in hepatic stellate cells to promote liver fibrosis through JAk/STAT pathway. | Biochem Pharmacol | 2025 | 40122149 | PubTator, text mining | PubMed |
| A multi-omics analysis of effector and resting treg cells in pan-cancer. | Comput Biol Med | 2025 | 40088713 | PubTator, text mining | PubMed |
| Interaction between nasal epithelial cells and Tregs in allergic rhinitis responses to allergen via CCL1/CCR8. | Front Immunol | 2025 | 40051629 | PubTator, text mining | PubMed |
| CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells. | Trends Immunol | 2025 | 39890548 | PubTator, text mining | PubMed |
| No bones about it: regulatory T cells promote fracture healing. | J Clin Invest | 2025 | 39817452 | PubTator, text mining | PubMed |
| Unleashing the Power of immune Checkpoints: A new strategy for enhancing Treg cells depletion to boost antitumor immunity. | Int Immunopharmacol | 2025 | 39764997 | PubTator, text mining | PubMed |
| Intervening CCL8-CCR8 Signaling Reduces Cutaneous Inflammation and Itch in Mice. | J Invest Dermatol | 2025 | 39761909 | PubTator, text mining | PubMed |
| CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity. | Br J Dermatol | 2025 | 39503255 | PubTator, text mining | PubMed |
| C-C Motif Ligand 7 and C-C Motif Chemokine Receptor 3 Dysregulation in Patients With Scrub Typhus and Association With Mortality. | J Infect Dis | 2025 | 39190223 | PubTator, text mining | PubMed |
| Novel Prognostic Markers for Skin Cutaneous Melanoma. | Clin Cosmet Investig Dermatol | 2024 | 39588228 | PubTator, text mining | PubMed |
| Progranulin-dependent repair function of regulatory T cells drives bone-fracture healing. | J Clin Invest | 2024 | 39509336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=5